Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Soos

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Biochemical and Biophysical Research Communications|June 15, 1994
Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II moleculesJ M Soos, H M Johnson
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 1, 1995
Type I interferon inhibition of superantigen stimulation: implications for treatment of superantigen-associated diseaseJ M Soos, H M Johnson
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Interferon-tau: prospects for clinical use in autoimmune disordersJ M Soos, H M Johnson
Journal of Neuroimmunology|March 1, 1993
Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitisJ M Soos, J Schiffenbauer, H M Johnson
Biochemical and Biophysical Research Communications|September 30, 1994
The C-terminus of IFN gamma is sufficient for intracellular functionB E Szente, J M Soos, H W Johnson
Journal of Neuroimmunology|May 1, 1997
CD4 T suppressor cells mediate interferon tau protection against experimental allergic encephalomyelitisM G Mujtaba, J M Soos, H M Johnson
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 1, 1996
Superantigens: structure and relevance to human diseaseH M Johnson, B A Torres, J M Soos
Revue Neurologique|November 11, 1998
Pathogenesis and treatment of central nervous system demyelinating diseaseS S Zamvil, J M Soos, H L Weiner
Medical Hypotheses|March 1, 1997
Superantigens as virulence factors in autoimmunity and immunodeficiency diseasesJ M Soos, J Schiffenbauer, B A Torres, et al.
Medical Hypotheses|August 1, 1994
Can superantigens trigger sudden infant death?J A Lindsay, H M Johnson, F M Wallace, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|June 15, 1994
Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II moleculesJ M Soos, H M Johnson
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 1, 1995
Type I interferon inhibition of superantigen stimulation: implications for treatment of superantigen-associated diseaseJ M Soos, H M Johnson
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Interferon-tau: prospects for clinical use in autoimmune disordersJ M Soos, H M Johnson
Journal of Neuroimmunology|March 1, 1993
Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitisJ M Soos, J Schiffenbauer, H M Johnson
Biochemical and Biophysical Research Communications|September 30, 1994
The C-terminus of IFN gamma is sufficient for intracellular functionB E Szente, J M Soos, H W Johnson
Journal of Neuroimmunology|May 1, 1997
CD4 T suppressor cells mediate interferon tau protection against experimental allergic encephalomyelitisM G Mujtaba, J M Soos, H M Johnson
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 1, 1996
Superantigens: structure and relevance to human diseaseH M Johnson, B A Torres, J M Soos
Revue Neurologique|November 11, 1998
Pathogenesis and treatment of central nervous system demyelinating diseaseS S Zamvil, J M Soos, H L Weiner
Medical Hypotheses|March 1, 1997
Superantigens as virulence factors in autoimmunity and immunodeficiency diseasesJ M Soos, J Schiffenbauer, B A Torres, et al.
Medical Hypotheses|August 1, 1994
Can superantigens trigger sudden infant death?J A Lindsay, H M Johnson, F M Wallace, et al.
Pageof 2